NCT01941927 2020-02-12Trametinib With GSK2141795 in BRAF Wild-type MelanomaUniversity of California, San FranciscoPhase 2 Completed20 enrolled 16 charts
NCT01958112 2019-05-31GSK1120212+GSK2141795 for Cervical CancerDana-Farber Cancer InstitutePhase 2 Terminated14 enrolled 10 charts